ConductScience.org, home

Gene · 657

Papers3,264

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1,501 to 1,520 of 3,264

Download this page as JSON
TitleJournalYearPMIDFound bySource
The Role of Ubiquitination in Regulating Embryonic Stem Cell Maintenance and Cancer Development.Int J Mol Sci201931151253PubTator, text miningPubMed
Tissue Preparation and Immunostaining of Mouse Craniofacial Tissues and Undecalcified Bone.J Vis Exp201931132049PubTator, text miningPubMed
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor.Sci Adv201931131319PubTator, text miningPubMed
Exome-wide search and functional annotation of genes associated in patients with severe tick-borne encephalitis in a Russian population.BMC Med Genomics201931122248PubTator, text miningPubMed
Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients.Cancer Manag Res201931118792PubTator, text miningPubMed
Mechanism of CK2.3, a Novel Mimetic Peptide of Bone Morphogenetic Protein Receptor Type IA, Mediated Osteogenesis.Int J Mol Sci201931117181PubTator, text miningPubMed
The current state of molecular testing in the treatment of patients with solid tumors, 2019.CA Cancer J Clin201931116423PubTator, text miningPubMed
Adenomatous Polyposis Coli Gene Mutations in 22 Chinese Pedigrees with Familial Adenomatous Polyposis.Med Sci Monit201931113927PubTator, text miningPubMed
Juvenile polyposis syndrome: A case report.Int J Surg Case Rep201931108454PubTator, text miningPubMed
Clinical and Histologic Overlap and Distinction Among Various Hamartomatous Polyposis Syndromes.Clin Transl Gastroenterol201931107726PubTator, text miningPubMed
Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma.J Int Med Res201931106632PubTator, text miningPubMed
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.
Cells201931100937PubTator, text miningPubMed
Pathogenesis and Cells of Origin of Barrett's Esophagus.Gastroenterology201931082367PubTator, text miningPubMed
Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy.Int J Mol Sci201931075880PubTator, text miningPubMed
Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation.Cancers (Basel)201931075839PubTator, text miningPubMed
Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).Front Pharmacol201931068801PubTator, text miningPubMed
Deregulation of Hepatic Mek1/2⁻Erk1/2 Signaling Module in Iron Overload Conditions.Pharmaceuticals (Basel)201931067696PubTator, text miningPubMed
BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature.BMC Med Genet201931064327PubTator, text miningPubMed
Looking for the hidden mutation: Bannayan-Riley-Ruvalcaba syndrome caused by constitutional and mosaic 10q23 microdeletions involving PTEN and BMPR1A.Am J Med Genet A201931062505PubTator, text miningPubMed
Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.BMC Cancer201931060523PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/657/papers?page=76